Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway

Fig. 3

Zn(ASA)2 improves electrocardiographic pattern. a Representative surface 12-lead ECG tracing; b corrected QT interval; c PQ-interval, and d ST-segment elevation. Values are mean ± SEM, n = 6-10. *P < 0.05 vs ZL, #P < 0.05 vs ZDF, $P < 0.05 vs Zn(ASA)2, nQTc = QT/(RR/f)1/2. Zn(ASA) 2 indicates a zinc complex of acetylsalicylic acid, ZDF Zucker diabetic fatty rats, ZL Zucker lean, RR corresponding to cardiac cycle length and f to frequency, nQTc QT intervals corrected with RR intervals

Back to article page